Taryn Losch-Beridon Selected Research

Lubiprostone

1/2022	Lubiprostone for Pediatric Functional Constipation: Randomized, Controlled, Double-Blind Study With Long-term Extension.
6/2021	Correction to: Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation.
1/2021	Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation.
1/2018	Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.
1/2018	Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
1/2017	Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taryn Losch-Beridon Research Topics

Disease

3	Constipation 01/2022 - 01/2021
3	Opioid-Induced Constipation 01/2018 - 01/2017
3	Pain (Aches) 01/2018 - 01/2017
1	Diarrhea 01/2018
1	Nausea 01/2018

Drug/Important Bio-Agent (IBA)

6	Lubiprostone FDA Link 01/2022 - 01/2017
2	Capsules (Microcapsules)IBA 06/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2018 - 01/2017
1	Methadone (Dolophine)FDA LinkGeneric 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2017

Therapy/Procedure

1	Therapeutics 01/2018
1	Analgesia 01/2017